| Schedule (route) | Endpoint | Vehicle | Dose | Treated/Control (%) | Observations |
|---|---|---|---|---|---|
| Q02DX033 (ip) | median survival time | saline | 12.5 mg/kg/injection | 101.0 | Antitumor endpoint evaluated on day 100; 10/10 animals surviving on day 16 |
| Q02DX033 (ip) | median survival time | saline | 25.0 mg/kg/injection | 105.0 | Antitumor endpoint evaluated on day 100; 10/10 animals surviving on day 16 |
| Q04DX006 (ip) | median survival time | saline | 6.25 mg/kg/injection | 105.0 | Antitumor endpoint evaluated on day 100; 10/10 animals surviving on day 16 |
| Q04DX006 (ip) | median survival time | saline | 12.5 mg/kg/injection | 100.0 | Antitumor endpoint evaluated on day 100; 10/10 animals surviving on day 16 |
| Q04DX006 (ip) | median survival time | saline | 25.0 mg/kg/injection | 108.0 | Antitumor endpoint evaluated on day 100; 10/10 animals surviving on day 16 |
| Q04DX006 (ip) | median survival time | saline | 50.0 mg/kg/injection | 105.0 | Antitumor endpoint evaluated on day 100; 10/10 animals surviving on day 16 |